Bloomington, IN, United States of America

Rajinder Matharu

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rajinder Matharu: Innovator in Liquid Formulations

Introduction

Rajinder Matharu is a notable inventor based in Bloomington, IN (US). He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on compounds that act at sulfonylurea receptors. His innovative work has led to the development of a unique liquid formulation that enhances the delivery of these compounds.

Latest Patents

Rajinder Matharu holds 1 patent for his invention titled "Liquid formulations of compounds active at sulfonylurea receptors." This invention provides liquid formulations that are suitable for intravenous and intra-arterial infusion. The formulations include compounds such as glibenclamide, tolbutamide, and repaglinide, among others. The liquid formulations can be concentrated solutions for storage or diluted for bolus injections and extended infusions. For instance, a formulation may contain at least about 0.05 mg/ml glibenclamide in a water-based solution with specific components, ensuring stability and ease of use.

Career Highlights

Rajinder Matharu is currently associated with Biogen Chesapeake LLC, where he continues to innovate in the field of pharmaceutical formulations. His work is characterized by a commitment to improving drug delivery systems, which can significantly impact patient care and treatment outcomes.

Collaborations

Rajinder collaborates with talented professionals in his field, including coworkers Sven Jacobson and Gillian Clarke. Their combined expertise contributes to the advancement of innovative solutions in pharmaceutical science.

Conclusion

Rajinder Matharu's contributions to liquid formulations of sulfonylurea receptor-active compounds exemplify the importance of innovation in the pharmaceutical industry. His work not only enhances drug delivery but also paves the way for future advancements in patient treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…